| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PTC THERAPEUTICS INC | 237,100 | 7,682,000 | 11.62% | ||
| 2 | XENOPORT INC | 1,295,778 | 7,114,000 | 10.76% | ||
| 3 | QUEST DIAGNOSTICS INC | 93,445 | 6,648,000 | 10.05% | ||
| 4 | ACORDA THERAPEUTICS | 145,509 | 6,225,000 | 9.41% | ||
| 5 | CENTENE CORP DEL | 86,139 | 5,669,000 | 8.57% | ||
| 6 | TEVA PHARMACEUTICAL INDS LTD | 75,286 | 4,942,000 | 7.47% | ||
| 7 | UNITEDHEALTH GROUP INC | 35,686 | 4,198,000 | 6.35% | ||
| 8 | EDWARDS LIFESCIENCES CORP | 47,230 | 3,730,000 | 5.64% | ||
| 9 | NEVRO CORP | 54,927 | 3,708,000 | 5.61% | ||
| 10 | ALKERMES PLC SHS | 29,350 | 2,330,000 | 3.52% | ||
| 11 | NEUROCRINE BIOSCIE COM USD0.001 | 40,888 | 2,313,000 | 3.50% | ||
| 12 | IMPAX LABORATORIES INC | 51,430 | 2,199,000 | 3.33% | ||
| 13 | AERIE PHARMACEUTICALS INC | 85,895 | 2,092,000 | 3.16% | ||
| 14 | PACIFIC BIOSCIENCES CALIF IN | 145,306 | 1,908,000 | 2.89% | ||
| 15 | AMICUS THERAPEUTICS INC | 195,206 | 1,893,000 | 2.86% | ||
| 16 | Anacor Pharmaceuticals Inc | 15,591 | 1,761,000 | 2.66% | ||
| 17 | SYNERGY PHARMACEUTICALS DEL COM NEW | 303,157 | 1,719,000 | 2.60% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001657134-16-000003, filed 2016.02.03).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
